Search - tctmd.com

Displaying 281 - 300 of 340

Sort: Relevancy | Date

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database

August 06, 2015

News Daily News

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

August 04, 2015

News Daily News

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

L.A. McKeown

August 03, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Industry News

Data Demonstrates Durability of Medtronic's VenaSeal Closure System, a Non-Tumescent, Non-Thermal and Non-Sclerosant Procedure for Chronic Venous Insufficiency

July 02, 2015

News Industry News

Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy

June 17, 2015

News Conference News ACC 2015

ERICCA: Remote Ischemic Preconditioning Fails to Improve Long-Term Outcomes After CABG

Yael L. Maxwell

March 16, 2015

News Conference News ACC 2015

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

L.A. McKeown

March 16, 2015

News Daily News

Analysis of SYNTAX Patients Documents Underuse of OMT

L.A. McKeown

March 05, 2015

News Daily News

Coronary Revascularization Performed Less Frequently

Todd Neale

January 12, 2015

News Daily News

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

L.A. McKeown

January 12, 2015

News Daily News

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

L.A. McKeown

January 12, 2015

News Daily News

Análisis de Gastos del ASCERT: CABG Más Caro que PCI pero con Mejores Resultados

L.A. McKeown

January 12, 2015

News Daily News

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

December 04, 2014

News Daily News

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

L.A. McKeown

November 06, 2014

News Daily News

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

August 20, 2014

Advertisement

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Data Demonstrates Durability of Medtronic's VenaSeal Closure System, a Non-Tumescent, Non-Thermal and Non-Sclerosant Procedure for Chronic Venous Insufficiency

Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy

ERICCA: Remote Ischemic Preconditioning Fails to Improve Long-Term Outcomes After CABG

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

Analysis of SYNTAX Patients Documents Underuse of OMT

Coronary Revascularization Performed Less Frequently

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

Análisis de Gastos del ASCERT: CABG Más Caro que PCI pero con Mejores Resultados

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content